JOT

Jupiter Orphan Therapeutics, Inc. is a specialty pharmaceutical company dedicated to developing treatments for rare diseases associated with single-gene defects. JOT is a Delaware corporation headquartered in Jupiter, Florida, USA. In its short period of operation, JOT has assembled a highly capable management and scientific team and defined three pipeline products, one of which has already entered the second phase.